Dr. Hui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 Tenth Ave S
Suite 2200
Minneapolis, MN 55407
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Oncologic Pathology, 2019 - 2020
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Dermatopathology, 2018 - 2019
- Brown UniversityResidency, Pathology-Anatomic and Clinical, 2014 - 2018
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2014
Certifications & Licensure
- MN State Medical License 2020 - 2025
- WI State Medical License 2020 - 2025
- PA State Medical License 2018 - 2021
- RI State Medical License 2014 - 2018
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 9 citationsCollagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.Yihong Wang, Murray B. Resnick, Shaolei Lu, Yiang Hui, Alexander S. Brodsky
Human Pathology. 2016-11-01 - 3 citationsT-complex-associated-testis-expressed 3 (TCTE3) is a novel marker for pancreatobiliary carcinomasChaohui Lisa Zhao, Yiang Hui, Li Juan Wang, Kara Lombardo, Dongfang Yang
Human Pathology. 2017-12-01 - 5 citationsDiffuse dermal angiomatosis mimicking inflammatory breast carcinoma.Yiang Hui, Christopher P. Elco, Nicole F. Heinl, Ana Lourenço, Doreen L. Wiggins
The Breast Journal. 2018-03-01
Journal Articles
- In Reply to Dr. Lambein Et Al “HER2 Protein Overexpression in Non‐Amplified Ductal Carcinoma in Situ: Quality Issue or Transcription Mechanisms Gone Awry?”Yiang Hui, Yihong Wang, Murray B Resnick, Histopathology
- Discordant HER2 Immunohistochemical Expression and Gene Amplification in Ductal Carcinoma in Situ ‐ Evaluating HER2 in Synchronous in Situ and Invasive CarcinomaYiang Hui, Shaolei Lu, Murray B Resnick, Yihong Wang, Histopathology
- Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers.Hui Y, Wang Y, Nam G, Fanion J, Sturtevant A, Lombardo KA, Resnick MB., Human Pathology, 1/6/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: